Naturally Formulated to Support Your Body's GLP-1 Pathway*
The abdomen, thigh, upper arm, and glute area are among the most common peptide injection sites, with the abdomen often being the preferred choice for many individuals
Patients who continue losing weight through the first year often see continued incremental improvements, while those who plateau in weight typically plateau in lipid changes as well
Theyre more likely to cause discomfort, inflammation, or even pain during or after the injection, which can make regular dosing unpleasant and less sustainable
The time required to witness visible results from intravenous glutathione therapy depends on the consistency of the treatment
The safety profile of DSIP is remarkable: 97% tolerability in clinical trials, and no lethal dose (LD50) has ever been determined in animals